Patents by Inventor Murray O. Robinson

Murray O. Robinson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7455963
    Abstract: Disclosed are nucleic acid molecules encoding cyclin E2 polypeptides. Also disclosed are methods of preparing the nucleic acid molecules and polypeptides, and methods of using these molecules.
    Type: Grant
    Filed: July 28, 2005
    Date of Patent: November 25, 2008
    Assignee: Amgen Inc.
    Inventors: Steven Roy Coats, Michael Brian Bass, Murray O. Robinson
  • Patent number: 7390891
    Abstract: Disclosed are nucleic acid molecules encoding polypeptides of the telomerase complex. Also disclosed are methods of preparing the nucleic acid molecules and polypeptides, and methods of using these molecules.
    Type: Grant
    Filed: October 16, 1997
    Date of Patent: June 24, 2008
    Assignee: Amgen Inc.
    Inventors: Lea Anne Harrington, Murray O. Robinson
  • Patent number: 6943238
    Abstract: Disclosed are nucleic acid molecules encoding novel cyclin E2 polypeptides. Also disclosed are methods of preparing the nucleic acid molecules and polypeptides, and methods of using these molecules.
    Type: Grant
    Filed: October 4, 2002
    Date of Patent: September 13, 2005
    Assignee: Amgen, Inc.
    Inventors: Steven Roy Coats, Michael Brian Bass, Murray O. Robinson
  • Publication number: 20030078370
    Abstract: Disclosed are nucleic acid molecules encoding novel cyclin E2 polypeptides. Also disclosed are methods of preparing the nucleic acid molecules and polypeptides, and methods of using these molecules.
    Type: Application
    Filed: October 4, 2002
    Publication date: April 24, 2003
    Applicant: Amgen Inc.
    Inventors: Steven Roy Coats, Michael Brian Bass, Murray O. Robinson
  • Patent number: 6174703
    Abstract: Disclosed are nucleic acid molecules encoding polypeptides that specifically bind telomerase RNA. Also disclosed are methods of preparing the nucleic acid molecules and polypeptides, and methods of using these molecules.
    Type: Grant
    Filed: November 2, 1998
    Date of Patent: January 16, 2001
    Assignees: Amgen Inc., Amgen Canada Inc.
    Inventors: Lea Anne Harrington, Murray O. Robinson
  • Patent number: 6165753
    Abstract: Disclosed are nucleic acid molecules encoding novel cyclin E2 polypeptides. Also disclosed are methods of preparing the nucleic acid molecules and polypeptides, and methods of using these molecules.
    Type: Grant
    Filed: December 30, 1998
    Date of Patent: December 26, 2000
    Assignee: Amgen Inc.
    Inventors: Steven Roy Coats, Michael Brian Bass, Murray O. Robinson
  • Patent number: 5981707
    Abstract: Disclosed are nucleic acid molecules encoding polypeptides that specifically bind telomerase RNA. Also disclosed are methods of preparing the nucleic acid molecules and polypeptides, and methods of using these molecules.
    Type: Grant
    Filed: April 15, 1998
    Date of Patent: November 9, 1999
    Assignees: Amgen Inc., Amgen Canada Inc.
    Inventors: Lea Anne Harrington, Murray O. Robinson
  • Patent number: 5973119
    Abstract: Disclosed are nucleic acid molecules encoding novel cyclin E2 polypeptides. Also disclosed are methods of preparing the nucleic acid molecules and polypeptides, and methods of using these molecules.
    Type: Grant
    Filed: June 5, 1998
    Date of Patent: October 26, 1999
    Assignee: Amgen Inc.
    Inventors: Steven Roy Coats, Michael Brian Bass, Murray O. Robinson
  • Patent number: 5919656
    Abstract: Disclosed are nucleic acid molecules encoding polypeptides that specifically bind telomerase RNA. Also disclosed are methods of preparing the nucleic acid molecules and polypeptides, and methods of using these molecules.
    Type: Grant
    Filed: November 15, 1996
    Date of Patent: July 6, 1999
    Assignees: Amgen Canada Inc., Amgen Inc.
    Inventors: Lea Anne Harrington, Murray O. Robinson
  • Patent number: 5489743
    Abstract: Transgenic mice and methods of preparing such mice are disclosed. The mice exhibit decreased platelet counts and/or megakaryocyte leukemia.
    Type: Grant
    Filed: January 19, 1993
    Date of Patent: February 6, 1996
    Assignee: Amgen Inc.
    Inventors: Murray O. Robinson, Pamela Hunt, Robert A. Bosselman